Ana Rita Rodrigues on the Impact of Post-Stroke Dysphagia
Ana Rita Rodrigues, Revisor for Health Science Reports at Wiley, shared on LinkedIn:
”Very pleased to see our work on the impact of post-stroke dysphagia highlighted, carried out at the Unidade Local de Saúde de Matosinhos and published in the Revista Portuguesa de Otorrinolaringologia e Cirurgia da Cabeça e Pescoço.
This study — of which I am the first author — analysed 137 patients assessed with fiberoptic endoscopic evaluation of swallowing (FEES) between 2018 and 2023, showing how dysphagia in the acute phase after stroke influences functional prognosis, length of hospital stay, and the risk of respiratory complications.
It is very gratifying to see this highly relevant topic featured by the My Otorrino platform, helping to raise awareness of the importance of early diagnosis and intervention.
A special thank you to the entire multidisciplinary team for their daily commitment to caring for patients with dysphagia.”
Read the full article here.
Article: Clinical and functional impact of oropharyngeal dysphagia after stroke: a retrospective study
Authors: Ana Rita Rodrigues, Adelaide Dias, Delfim Duarte, Nuno Oliveira
Stay updated on all scientific advances with Hemostasis Today.
-
May 13, 2026, 07:35Ifeanyichukwu Ifechidere: Why DIC is the Condition That Humbles even the Most Experienced Scientists
-
May 13, 2026, 07:26Genoveva Uzunova: Why It’s Time to Close the Sex Variable Gap in Healthcare
-
May 13, 2026, 07:09Auston Cherbonneaux: Why Erythritol Just Joined the High-Hazard List
-
May 13, 2026, 06:48Akshat Jain: Transforming Sickle Cell Care With Practical Apheresis Frameworks
-
May 13, 2026, 06:35Dima Shulkin: How Neutrophil Extracellular Traps Shape ACS
-
May 13, 2026, 05:50Danny Hsu: Global Maternal VTE Awareness and Opportunities for Prevention
-
May 13, 2026, 05:50Ney Carter Borges: Clinical Cardiovascular Polygenic Risk Report for 8 Conditions
-
May 13, 2026, 05:49Kalyan Roy: A New Blood Group System Has Been Discovered
-
May 13, 2026, 05:07Azin Alizadehasl: Unraveling DIC in Cancer-Driven Coagulopathy